Breaks Categories: News

WednesdayJan 03, 2018 9:43 am

HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Recaps 2017 Successes in Update

PotNetwork Holding, Inc. (OTC: POTN) this morning shared its outlook on what it called a “solid year of record breaking success” in 2017. Per the news release, the company’s management team has established “a solid infrastructure for success” since acquiring First Capital Venture Co. and Diamond CBD. Highlights related to these corporate milestones include strengthening the company’s value and achieving share appreciation from $0.01 in January 2017 to $0.10 in December 2017. PotNetwork also established an esteemed advisory board to aid in the research and development of new products, brought on a distinguished Florida physician as its chief executive officer…

Continue Reading

TuesdayJan 02, 2018 12:05 pm

HempNewsBreaks – EVIO, Inc. (EVIO) Acquires Stake in C3 Labs, LLC

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that it has completed the acquisition of 60 percent of C3 Labs, LLC, one of the nation’s first cannabis-focused contract research organizations. EVIO also maintains the option to purchase the remaining ownership stake in C3 Labs for an initial period of three years, subject to C3 member approval. “The addition of C3 Labs to the EVIO network is a tremendous milestone for EVIO Inc.,” William Waldrop, CEO of EVIO, stated in the news release.…

Continue Reading

TuesdayJan 02, 2018 11:12 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Provides Post-Holiday Update on Baijiu Sales

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning offered shareholders a post-holiday update on CBD Biotechnology Co. Ltd.’s Yantai 1985 baijiu sales. Through a partnership with a proven leader in the Chinese baijiu market, the company’s wholly-owned foreign enterprise has commenced an initial marketing campaign on Chinese mobile app Today’s Headlines that it anticipates will drive revenues of approximately $1.8 million in 2018. These projections are supported by the early success of CBD Biotechnology’s advertising efforts. Notably, the digital ad campaign generated revenues of over $29,000 in its first week. “The marketing-to-revenue ratio for the initial sales campaign on…

Continue Reading

TuesdayJan 02, 2018 10:32 am

HempNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Receives Cannabis Oil Production License from Health Canada

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has been licensed by Health Canada to produce medical cannabis oils. Per the update, Health Canada will conduct a final inspection when ABcann has saleable extracted finished products. ABcann expects to complete this process in the first quarter of 2018. “Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed,” Barry Fishman, CEO of ABcann, stated in the news release. “The expansion and innovation of our product lines…

Continue Reading

TuesdayJan 02, 2018 9:44 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Adds Dr. Brian O’Connor to Advisory Board

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced the addition of Dr. Brian O’Connor, a consultant in respiratory medicine, to its advisory board. Per the update, O’Connor is a clinical expert in the areas of asthma, chronic obstructive pulmonary disease (“COPD”), allergic disease and lung cancer. He is also an active clinical researcher committed to investigating new treatment strategies in airways disease. “Dr. O’Connor brings a great reputation of clinical excellence and scholarly research,” Dr. Lui Franciosi, CEO of Veritas, stated in the news release. “He will advise us on…

Continue Reading

FridayDec 29, 2017 9:44 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Visits Clinical Trial Facility in San Juan, Puerto Rico

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico. Per the release, this will be the site where the company’s research arm, Cannevert Therapeutics Ltd. (“CTL”), will be conducting its first human study of CTL-X, a cannabis strain targeting the pain management market. Speaking about the FDI clinical trial facility in this morning's update, Veritas CEO Lui Franciosi stated, “I was very impressed by their Phase I and Phase II-III clinical trial…

Continue Reading

ThursdayDec 28, 2017 10:16 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Subsidiary Receives Dealer License from Health Canada

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd. (“CTL”), a dealer license allowing it to possess, analyze, sale, send, transport and deliver cannabis, hemp and related products. Per the release, reception of this license marks a “significant step” for CTL as it seeks to discover and develop new therapeutic cannabis strains while also providing commercial chemical and biological testing services for licensed producers under Health Canada guidelines. “We are excited that Cannevert scientists will now not only…

Continue Reading

WednesdayDec 27, 2017 11:33 am

HempNewsBreaks – Global Payout, Inc. (GOHE) CEO Releases Letter to Shareholders

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced the release of a year-end letter to shareholders from CEO James Hancock. In the letter, Hancock recaps what he calls an “especially active, yet successful” year for both Global Payout and its majority-owned subsidiary, MoneyTrac Technology, Inc. In particular, he notes the company’s appointment of Vanessa Luna to the position of chief operating officer as a major milestone in Global Payout’s strategic plans. “Without question, one of the most critical events of the year involved the appointment of Ms. Vanessa Luna as Global's Chief Operating Officer,” Hancock stated in…

Continue Reading

TuesdayDec 26, 2017 9:51 am

HempNewsBreaks – EVIO, Inc. (EVIO) Licensee Attains ISO 17025 Accreditation

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that its Colorado licensee, PhytaTech CO, has attained ISO 17025 accreditation, which requires consistent production of precise and accurate tests and implementation of a rigorous quality management system. Per the update, ISO 17025 is the highest recognized quality standard for calibration and testing laboratories. “As one of only a few Colorado Cannabis Testing labs that have achieved ISO 17025 accreditation, PhytaTech is at the leading edge of testing in the state,” Stephen Goldman, PhytaTech’s…

Continue Reading

TuesdayDec 26, 2017 9:11 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Looks to Blockchain Technology as Possible Solution for Issues Facing Cannabis Industry

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced plans to leverage its existing team of technology and health care experts in order to develop methods of utilizing blockchain technology in areas such as product identification assurance (PIA). The importance of PIA was reaffirmed in a recent study published by JAMA, which indicated that nearly 70 percent of all cannabidiol products sold online are mislabeled. “We understand the unique challenges facing the cannabis industry and believe that our team has the expertise to be the first to…

Continue Reading